1 Views
administrator
07/07/23
When Alfred Samuels was diagnosed with prostate cancer, he was told his prognosis was poor. Then he joined the STAMPEDE trial and began being treated with abiraterone, which changed everything.
Find out more about our new strategy: https://www.icr.ac.uk/strategy
-
Category
Show more
Facebook Comments
No comments found